Relationship between a Weighted Multi-Gene Algorithm and Blood Pressure Control in Hypertension

Area of Science:

• Genetics
• Cardiovascular Medicine
• Pharmacogenomics

Background:

• Hypertension (HTN) is a complex, heritable cardiovascular disease impacting multiple organ systems.
• Current clinical guidelines lack a multi-gene approach for guiding blood pressure (BP) pharmacotherapy.
• Genetic factors significantly influence individual responses to antihypertensive medications.

Purpose of the Study:

• To investigate the utility of a weighted multi-gene algorithm in predicting pharmacotherapy response for hypertension.
• To assess if a multi-gene based algorithm can personalize drug selection for better BP management.

Main Methods:

• A cohort of 384 non-smokers with a family history of HTN was analyzed.
• Seventeen functional genotypes were weighted by prior effect sizes and incorporated into an algorithm.
• Pharmacotherapy recommendations were ranked (1-4) based on algorithmic genotype assessment; BP and medication data were tracked over three years.

Main Results:

• No significant difference in BP at diagnosis between patients matching the algorithm's top recommendation (n=92) and those who did not (n=292).
• Patients matching the top recommendation showed a significantly greater BP reduction from diagnosis to nadir.
• The difference between diagnosis and 1-year average BP was lower in patients who matched the algorithm's primary drug recommendation.

Conclusions:

• A weighted multi-gene algorithm shows potential association with improved blood pressure response to pharmacotherapy in hypertensive patients.
• This genetic-based approach may offer a pathway toward more personalized hypertension treatment strategies.
• Further research is warranted to validate and implement multi-gene algorithms in clinical practice for hypertension management.